AzTrials
AzTrials

Platelet-rich FibrinNCT05866965

Effect of Platelet-rich Fibrin on Soft Tissue, Periodontal Pocket Healing and Alveolar Bone Height After Third Molar Surgery

A study testing PRF and standard third molar surgical removal in people with Platelet-rich Fibrin, run by Lam Cu Phong at 1 site in Vietnam.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A Randomized, controlled clinical trial and split-mouth design was performed to assess and compare the effect of platelet-rich fibrin (PRF) on soft tissue healing, periodontal pocket depth and alveolar bone height distal to second molar of the study and control groups after third molar surgical removal. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Platelet-rich Fibrin
What is being tested?
PRF and standard third molar surgical removal
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteVietnam
Study dates
1 Dec 2019to 1 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patient over 18 years old.
  • Good general health.
  • Bilateral lower third molars equivalent in inclination and Pell and Gregory's impaction classification (classification II, III and B, C). The assessment of equivalence between two mandibular third molars was determined on the panoramic radiograph.
  • The difference of third molar inclination on both sides not greater than 15 degrees.
  • The patient consented to participate in the study after hearing clearly the explanation of purposes and requirements of the study.

Who cannot join

  • Patients with any systemic disease contraindicated for surgery.
  • Presence of acute inflammation or infection at third molar areas.
  • Patients refused to participate in the study, did not comply with treatment or did not come to the follow-up examination as required.
  • The difference in surgical time between the two groups was more than 10 minutes.

Trial locations and contacts

1 site in 1 country.

Vietnam1 site
  • University of Medicine and Pharmacy

    Ho Chi Minh City, 700000

Other trials in Vietnam

About this study

A Randomized, controlled clinical trial and split-mouth design was performed to assess and compare the effect of platelet-rich fibrin (PRF) on soft tissue healing, periodontal pocket depth and alveolar bone height distal to second molar of the study and control groups after third molar surgical removal.

Sample include of participants who had indication of impacted lower third molars extraction on both sides with symmetrically orientation and same difficult index. All participants had same extraction protocol on both side at Department of Oral surgery, Faculty of Odonto-stomatology, University of Medicine and Pharmacy, Ho Chi Minh City.

Soft tissue healing, periodontal pocket depth and distal bone height were evaluation by an independent investigator.

Being tested
PRF, standard third molar surgical removal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PRFOther

    centrifuge patient's blood to collect 1 block of yellowish condensed fibrin, which is platelet-rich fibrin

  • standard third molar surgical removalOther

    standard third molar surgery following surgical protocol of Department of Oral Surgery, University of Medicine and Pharmacy

Study groups in NCT05866965
Study groupRoleWhat they receive
controlActive comparatorstandard third molar surgery following surgical protocol of Department of Oral Surgery, University of Medicine and Pharmacy
Receives: Other: standard third molar surgical removal
PRFExperimentalPRF was applied in third molar socket after removal following surgical protocol of Department of Oral Surgery, University of Medicine and Pharmacy
Receives: Other: PRF

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. periodontal pocket depth

    periodontal pocket depth at distal buccal and distal lingual side of second molar

    Measured: 1rst postoperative month

  2. periodontal pocket depth

    periodontal pocket depth at distal buccal and distal lingual side of second molar

    Measured: 3rst postoperative month

  3. periodontal pocket depth

    periodontal pocket depth at distal buccal and distal lingual side of second molar

    Measured: 6rst postoperative month

  4. distal bone resorption

    resorption of alveolar bone height distal to second molar

    Measured: 3rd postoperative month

  5. distal bone resorption

    resorption of alveolar bone height distal to second molar

    Measured: 6th postoperative month

Secondary outcomes (2)
  1. soft tissue healing index

    soft tissue healing around third molar socket

    Measured: 3rd postoperative day

  2. soft tissue healing index

    soft tissue healing around third molar socket

    Measured: 7th postoperative day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 May 2023
  2. Study start1 Dec 2019
  3. Primary completion1 Jun 2021
  4. Study completion1 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Crossover
Model description
split-mouth study, 1 side would be the study side and other side would be control side
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05866965
Sponsor's protocol ID
lamphongrhm
Status last verified
May 2023
First submitted
27 Apr 2023
Last updated
19 May 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing PRF and standard third molar surgical removal in people with Platelet-rich Fibrin, run by Lam Cu Phong at 1 site in Vietnam.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Vietnam. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

periodontal pocket depth (time frame: 1rst postoperative month). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in